Influenza Vaccine

Most healthy adults recover from influenza within a few days but some people, especially those aged 65 and over, and those with certain chronic illnesses like heart or lung disease, can develop complications. These can include pneumonia or heart failure, which can be fatal.

Follow the links below to find information you will need if you are considering immunisation against influenza.

Reviewed December 2011

Printer friendly page Printer friendly page

Related HealthInsite Topics

Systematic Reviews of Influenza Vaccines

HealthInsite Topic Page
Links to systematic reviews of the evidence for the effectiveness of the influenza vaccine

24 Resources Found

Results 1 to 20 displayed.     1  2 

Title:   Australian Influenza Vaccine Committee (AIVC)
Publisher:   Australian Government Department of Health and Ageing
Description:   Recommendations from the Australian Influenza Vaccine Committee (AIVC) for the composition of influenza vaccine in Australia.
Date:   Oct 2011
Title:   The TGA and the USA FDA agree about problems at CSL Biotherapies
Publisher:   Australian Government Department of Health and Ageing
Description:   The TGA wishes to clarify some aspects of this action and what it means for public safety
Date:   Jul 2011
Title:   CSL Biotherapies: 'Warning Letter' issued by the United States' Food and Drug Administration
Publisher:   Australian Government Department of Health and Ageing
Description:   The United States' Food and Drug Administration (FDA) has issued a 'Warning Letter' to CSL Biotherapies (CSL) following their audit of CSL's manufacturing facility
Date:   Jun 2011
Title:   Seasonal influenza vaccines
Publisher:   Australian Government Department of Health and Ageing
Description:   The approved indication for each seasonal influenza vaccine and the recommendations for their use in children.
Date:   Nov 2011
Title:   Influenza vaccine (flu vaccine)
Publisher:   Virtual Medical Centre.com
Description:   Flu vaccines are products given to people so that their immune systems are better able to recognise flu (influenza) infection, and therefore has a better chance of fighting it off.
Date:   Mar 2011
Title:   Antivirals & vaccines
Publisher:   Australian Government Department of Health and Ageing
Description:   Medicines known as antivirals may have some effectiveness in preventing the development of infection in people exposed to the influenza virus. When used as a treatment, antivirals can reduce the duration of symptoms and illness.
Date:   Jan 2011
Title:   Response to the West Australian (Stokes) Review into the handling of AEFIs following 2010 seasonal flu vaccination
Publisher:   Australian Government Department of Health and Ageing
Description:   It is hoped that this response to the Stokes Review will enable a greater public understanding of the nature of the controls that are in place and that do work effectively to protect public health in Australia.
Date:   Nov 2010
Title:   Latex in pandemic vaccine syringes: TGA laboratory investigation
Publisher:   Australian Government Department of Health and Ageing
Description:   In October 2009 an anaphylactic reaction to the Panvax H1N1 pandemic influenza vaccine was reported in Western Australia in a person known to have a pre-existing latex allergy.
Date:   Oct 2010
Title:   Composition of Australian influenza vaccine for the 2011 season
Publisher:   Australian Government Department of Health and Ageing
Description:   This page contains information on the recommended influenza vaccine for the Southern Hemisphere winter 2011.
Date:   Oct 2010
Title:   Overview of vaccine regulation and safety monitoring and investigation into adverse events following 2010 seasonal influenza vaccination in young children
Publisher:   Australian Government Department of Health and Ageing
Description:   Since Edward Jenner's creation of the world's first vaccine against smallpox over 200 years ago, human beings have been benefiting from vaccination.
Date:   Oct 2010
Title:   Suspected adverse reactions to Panvax® reported to the TGA
Publisher:   Australian Government Department of Health and Ageing
Description:   The national immunisation program with Panvax began on 30 September 2009. The TGA has been closely monitoring any side effects from the use of the vaccine.
Date:   Oct 2010
Title:   Analysis of febrile convulsions following immunisation in children following monovalent pandemic H1N1 vaccine (Panvax/Panvax Junior, CSL)
Publisher:   Australian Government Department of Health and Ageing
Description:   In April 2010, an ATAGI-TGA joint working group was established to provide advice to the Chief Medical Officer on adverse events following the 2010 trivalent seasonal influenza vaccine (TIV). In September 2010, this group was reconvened to re-examine the rate of febrile convulsions following administration of the monovalent pandemic H1N1 influenza vaccine, Panvax/Panvax Junior (CSL) in young children.
Date:   Sep 2010
Title:   Investigation into febrile reactions in young children following 2010 seasonal trivalent influenza vaccination
Publisher:   Australian Government Department of Health and Ageing
Description:   WA Health suspended this year's program on 22 April 2010 following reports of an apparent increase in febrile reactions following vaccination during March-April over the number that would be expected from records for 2008 and 2009, despite a similar uptake of seasonal vaccine in 2009 and 2010.
Date:   Sep 2010
Title:   Panvax Junior - withdrawal
Publisher:   Australian Government Department of Health and Ageing
Description:   Stability testing by the TGA of the pandemic influenza vaccine for children, Panvax H1N1 Junior, has shown a decline in potency of the product which is supplied in 0.25 ml pre-filled syringes.
Date:   Aug 2010
Title:   Seasonal Flu Vaccine and Young Children
Publisher:   HealthInsite Editorial Team
Description:   Due to a spike in the numbers of young children in Western Australia experiencing fever and convulsions following seasonal flu vaccinations, Australia's Chief Medical Officer, Professor Jim Bishop, is advising all GPs and immunisation providers to stop giving seasonal flu vaccine to children five years and under until a cause is established.
Date:   Apr 2010
Title:   Western Australian reports of adverse reactions to 2010 seasonal flu vaccine in children
Publisher:   Australian Government Department of Health and Ageing
Description:   The Therapeutic Goods Administration (TGA) is investigating reports of an increase in adverse events to the seasonal flu vaccine in Western Australia (WA), where all children 6 months to 5 years have been offered a free seasonal flu vaccination.
Date:   Apr 2010
Title:   H1N1 immunisation: too much too soon?
Publisher:   Australian Prescriber
Description:   As H1N1 (swine flu) spread rapidly throughout the world it caused not only a 'pandemic' but also widespread fear leading to a mass vaccination campaign. Studies are needed to answer basic questions on the true safety and efficacy of influenza vaccines.
Date:   Apr 2010
Title:   TGA approves Pandemic (H1N1) 2009 influenza vaccine for use in children aged from 6 months of age
Publisher:   Australian Government Department of Health and Ageing
Description:   Australia's medicines regulator, the TGA, has today approved the use of Panvax H1N1 influenza vaccine to include children aged from 6 months of age.
Date:   Dec 2009
Title:   Pandemic (H1N1) 2009 human swine influenza: frequently asked questions and answers about vaccine safety
Publisher:   Queensland Health
Description:   This fact sheet provides questions and answers about the Pandemic(H1N1) human swine influenza vaccine.
Date:   Sep 2009
Title:   TGA approves vaccine against Pandemic (H1N1) 2009 influenza
Publisher:   Australian Government Department of Health and Ageing
Description:   Australia's medicines regulator, the TGA, has today approved the registration of Panvax H1N1 influenza vaccine, for use in adults and children 10 years of age and over.
Date:   Sep 2009

Results 1 to 20 displayed.     1  2